DCGO DocGo
- 3.360
- +0.060+1.82%
- 3.390
- +0.030+0.89%
DocGo News
DocGo(DCGO.US) Director Buys US$34,000 in Common Stock
$DocGo(DCGO.US)$ Director Burdiek Michael J purchased 10,000 shares of common stock on May 14, 2024 at an average price of $3.4 for a total value of $34,000.Source: Announcement What is statement of c
DocGo(DCGO.US) Officer Buys US$31,300 in Common Stock
$DocGo(DCGO.US)$ Officer Tendler Ely D purchased 10,000 shares of common stock on May 13, 2024 at an average price of $3.13 for a total value of $31,300.Source: Announcement What is statement of chang
DocGo(DCGO.US) Officer Buys US$78,750 in Common Stock
$DocGo(DCGO.US)$ Officer Bienstock Lee purchased 25,000 shares of common stock on May 13, 2024 at an average price of $3.15 for a total value of $78,750.Source: Announcement What is statement of chang
DocGo Inc. (NASDAQ:DCGO) Q1 2024 Earnings Call Transcript
Earnings Call Summary | DocGo(DCGO.US) Q1 2024 Earnings Conference
The following is a summary of the DocGo Inc. (DCGO) Q1 2024 Earnings Call Transcript:Financial Performance:DocGo's Q1 2024 revenue reached $192.1 million and recorded an adjusted EBITDA of $24.1 milli
DocGo Inc.'s (NASDAQ:DCGO) Recent 16% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures
Key Insights Institutions' substantial holdings in DocGo implies that they have significant influence over the company's share price 51% of the business is held by the top 20 shareholders Insider
What You Need To Know About The DocGo Inc. (NASDAQ:DCGO) Analyst Downgrade Today
Today is shaping up negative for DocGo Inc. (NASDAQ:DCGO) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. This report focused on revenue estimate
DocGo Inc. (DCGO) Q1 2024 Earnings Call Transcript
DocGo Inc. (DCGO) Q1 2024 Earnings Call Transcript
DocGo Inc (DCGO) Surpasses Analyst Revenue Forecasts With Strong Q1 2024 Performance
DocGo First Quarter 2024 Earnings: EPS Beats Expectations
DocGo Is Maintained at Buy by Needham
DocGo Is Maintained at Buy by Needham
Needham: Maintaining the DoCGO (DCGO.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $10.00 to $7.00.
Needham: Maintaining the DoCGO (DCGO.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $10.00 to $7.00.
DocGo Is Maintained at Overweight by Cantor Fitzgerald
DocGo Is Maintained at Overweight by Cantor Fitzgerald
DocGo Price Target Cut to $5.00/Share From $11.00 by Cantor Fitzgerald
DocGo Price Target Cut to $5.00/Share From $11.00 by Cantor Fitzgerald
Cantor Fitzgerald Maintains Overweight on DocGo, Lowers Price Target to $5
Cantor Fitzgerald analyst Sarah James maintains DocGo (NASDAQ:DCGO) with a Overweight and lowers the price target from $11 to $5.
Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating
Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating.
DocGo (DCGO) Has a New Rating From Northland Securities
Analysts Are Bullish on Top Healthcare Stocks: DocGo (DCGO), Avadel Pharmaceuticals (AVDL)
Buy Rating on DocGo: Strong Growth Potential and Financial Health Despite Revenue Base Changes
DocGo Inc (DCGO) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and Strategic ...
Analysis
Price Target
No Data
